STORMI BAKER: Open Payments
NPI 1932966314 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 40 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $139 · 2025 $530
Food & beverage: $419Education: $111
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 27 | $210 |
| Teva Pharmaceuticals USA, Inc. | 5 | $173 |
| E.R. Squibb & Sons, L.L.C. | 3 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| ABBVIE INC. | 2 | $32 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
Products named: INGREZZA, AUSTEDO XR, COBENFY, CAPLYTA, VRAYLAR, INVEGA SUSTENNA, UZEDY.
Industry payments across TX — which companies pay providers there.
